Related references
Note: Only part of the references are listed.Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine Triphosphate
Lili Feng et al.
NEOPLASIA (2011)
On-target Inhibition of Tumor Fermentative Glycolysis as Visualized by Hyperpolarized Pyruvate
Pankaj Seth et al.
NEOPLASIA (2011)
The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway
Min Fang et al.
CELL (2010)
CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
Xiaofeng Sun et al.
GASTROENTEROLOGY (2010)
Deletion of CD39 on Natural Killer Cells Attenuates Hepatic Ischemia/Reperfusion Injury in Mice
Guido Beldi et al.
HEPATOLOGY (2010)
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer
Han Xie et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Taro Hitosugi et al.
SCIENCE SIGNALING (2009)
Ectonucleoside Triphosphate Diphosphohydrolase Type 5 (Entpd5)-Deficient Mice Develop Progressive Hepatopathy, Hepatocellular Tumors, and Spermatogenic Arrest
R. Read et al.
VETERINARY PATHOLOGY (2009)
Deletion of Cd39/Entpd1 results in hepatic insulin resistance
Keiichi Enjyoji et al.
DIABETES (2008)
The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism
Beldi Guido et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Regulated Catalysis of Extracellular Nucleotides by Vascular CD39/ENTPD1 Is Required for Liver Regeneration
Guido Beldi et al.
GASTROENTEROLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis
Guido Beldi et al.
HEPATOLOGY (2008)
mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex
John T. Cunningham et al.
NATURE (2007)
Disordered purinergic signaling inhibits pathological angiogenesis in Cd39/Entpd1-null mice
Shaun W. Jackson et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors
Yu Chen et al.
SCIENCE (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
RanBPM associates with CD39 and modulates ecto-nucleotidase activity
Yan Wu et al.
BIOCHEMICAL JOURNAL (2006)
NF-κB inhibition:: A double-edged sword in cancer?
E Pikarsky et al.
EUROPEAN JOURNAL OF CANCER (2006)
Regulation of human Hepatocytes by P2Y receptors:: Control of glycogen phosphorylase, Ca2+, and mitogen-activated protein kinases
CJ Dixon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation
SC Robson et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
The role of autophagy in cancer development and response to therapy
Y Kondo et al.
NATURE REVIEWS CANCER (2005)
Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes
S Thevananther et al.
HEPATOLOGY (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
ERK, PKC and PI3K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line
MC Jacques-Silva et al.
ONCOLOGY (2004)
Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors
H Sikder et al.
CANCER CELL (2003)
Share Paper
